These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6875521

  • 21. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC, Murphy BR, Fries LF, Adler WH, Clements ML.
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [Abstract] [Full Text] [Related]

  • 22. Influenza virus vaccination of patients with chronic lung disease.
    Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, Lusk RH.
    Chest; 1997 Nov 05; 112(5):1221-33. PubMed ID: 9367461
    [Abstract] [Full Text] [Related]

  • 23. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M, Aqrawi LA, Zhou F, Pedersen G, Trieu MC, Zhou P, Cox RJ.
    Scand J Immunol; 2015 May 05; 81(5):305-17. PubMed ID: 25737202
    [Abstract] [Full Text] [Related]

  • 24. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Manenti A, Tete SM, Mohn KG, Jul-Larsen Å, Gianchecchi E, Montomoli E, Brokstad KA, Cox RJ.
    Vaccine; 2017 Jan 03; 35(1):191-198. PubMed ID: 27789145
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.
    Ann Intern Med; 1992 Oct 15; 117(8):625-33. PubMed ID: 1530193
    [Abstract] [Full Text] [Related]

  • 27. Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57.
    Wareing MD, Tannock GA.
    Vaccine; 2003 Jul 04; 21(23):3097-100. PubMed ID: 12804835
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
    Wright PF, Murphy BR, Kervina M, Lawrence EM, Phelan MA, Karzon DT.
    Infect Immun; 1983 Jun 04; 40(3):1092-5. PubMed ID: 6852914
    [Abstract] [Full Text] [Related]

  • 30. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 31. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 06; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 32. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M, Greenbaum E, Ben-Yehuda A, Oster M, Yeu'l E, Heimann S, Levy R, Friedman G, Zakay-Rones Z.
    Vaccine; 2003 Mar 07; 21(11-12):1180-6. PubMed ID: 12559796
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
    Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N.
    J Infect Dis; 1996 Feb 07; 173(2):453-6. PubMed ID: 8568310
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.
    Cox RJ, Brokstad KA, Ogra P.
    Scand J Immunol; 2004 Jan 07; 59(1):1-15. PubMed ID: 14723616
    [Abstract] [Full Text] [Related]

  • 37. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG, Gagarinova VM, Gorev NE, Shadrin AS.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr 07; (4):79-84. PubMed ID: 6868890
    [Abstract] [Full Text] [Related]

  • 38. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
    Clements ML, Betts RF, Tierney EL, Murphy BR.
    J Clin Microbiol; 1986 Jul 07; 24(1):157-60. PubMed ID: 3722363
    [Abstract] [Full Text] [Related]

  • 39. Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines.
    Gruber WC, Hinson HP, Holland KL, Thompson JM, Reed GW, Wright PF.
    J Infect Dis; 1993 Nov 07; 168(5):1282-5. PubMed ID: 8228364
    [Abstract] [Full Text] [Related]

  • 40. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S, Süss J, Oehring H, Schmidt J.
    Acta Virol; 1982 Dec 07; 26(6):466-73. PubMed ID: 6132540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.